small-cap

One Lithium-boron Producer to Sell- INR

Jul 12, 2022 | Team Kalkine

Read Time :5 min

ioneer Ltd

INR Details

ioneer Ltd (ASX: INR) is an emerging lithium-boron producer which is set to develop one of the most attractive lithium projects globally. Its 100%-owned Rhyolite Ridge Lithium-Boron Project in Nevada, USA provides important foundation for the company to become a responsible as well as profitable producer of the necessary materials.

Results Performance (Half-year Ended December 2021)

The net assets of the company rose to $283.4 million as at 31 December 2021, from $191.1 million at 30 June 2021. This was mainly because of the placement to Sibanye-Stillwater as well as continued investment in the Rhyolite Ridge asset.
Notably, exploration as well as evaluation expenditure for the H1 FY 2022 was $18.9 million and was mainly related to advancing the engineering and permitting of the Project.
The company has reported cash on hand, at 31 December 2021, of $149.0 million.

Recent Updates

INR has announced the retirement of Mr. Julian Babarczy as the Non-Executive Director of the company.

In the release dated 1^st July 2022, the company announced the commencement of trading on the NASDAQ under an ADR listing.

Technical Overview:

Chart:

Source: REFINITIV

Note: Purple Color Line Reflects RSI (14-Period)

INR prices witnessed a gradual recovery in the prices from the key supporting levels. The stock was hovering in a rising wedge pattern on a daily chart but the stock recently broke its rising wedge pattern that indicates the prices might decline in the coming period. RSI (14-period) is trading at moderate zone at~53.76 on a daily chart that indicates indecision in the stock prices. Immediate support levels are AUD 0.406 and AUD 0.385 while key resistance levels are AUD 0.500 and AUD 0.580.

Stock Recommendation

Considering the resistance and target level achievement, current trading levels and risks associated, we are of the view that it is prudent to exit the position at the current levels.

Hence, we give a 'Sell' rating on the stock at the current price of AUD 0.463 per share (as of July 12, 2022, at 10:53 AM GMT +10, Sydney, Australia).

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Small-Cap

Watch Out for One NASDAQ- Listed Biotechnology Services Stock – Inotiv Inc